Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
- Litton, J.K.
- Hurvitz, S.A.
- Mina, L.A.
- Rugo, H.S.
- Lee, K.-H.
- Gonçalves, A.
- Diab, S.
- Woodward, N.
- Goodwin, A.
- Yerushalmi, R.
- Roché, H.
- Im, Y.-H.
- Eiermann, W.
- Quek, R.G.W.
- Usari, T.
- Lanzalone, S.
- Czibere, A.
- Blum, J.L.
- Martin, M.
- Ettl, J.
ISSN: 1569-8041, 0923-7534
Argitalpen urtea: 2020
Alea: 31
Zenbakia: 11
Orrialdeak: 1526-1535
Mota: Artikulua